FDA Regulatory Friday, September 4, 2026 +0.75 Positive

FDA Acts to Avert Neonatal PN Supply Gap

The FDA is taking steps to maintain access to life-saving neonatal starter parenteral nutrition following concerns over a potential supply gap, aligning with the administration's commitment to protecting vulnerable patients.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day